AI Article Synopsis

  • The study aimed to develop a method for detecting spinal tuberculosis (TB) using the ELISPOT assay and investigate the efficacy of the CFP10/ESAT6 fusion protein in diagnosing spinal TB.
  • Data were collected from patients suspected of having spinal TB in two hospitals over 18 months, with a focus on comparing ELISPOT with traditional diagnostic methods.
  • The results indicated that the ELISPOT assay demonstrated higher sensitivity and specificity (82.7% and 87.2%, respectively) compared to conventional tests like the PPD skin test and antibody detection, suggesting it is a reliable supplementary diagnostic tool for spinal TB.

Article Abstract

Objective: To establish a method of detecting spinal tuberculosis (TB) infection by enzyme-linked immunospot (ELlSPOT) assay and evaluate the value of CFP10/ESAT6 fusion protein for diagnosis of spinal TB.

Methods: Suspected spinal TB patients were prospectively recruited in two hospitals (First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine; Nanfang Hospital, Southern Medical University) from May 2012 to December 2013. Data on clinical characteristics of the patients and conventional laboratory results were collected. Compare and analyze the positive detection rate in spinal TB diagnosis by different methods including ELISPOT detection and conventional detection methods.

Results: 47 patients with spinal TB had available biopsy or surgical specimens for histopathological examination and 41 specimens had pathological features consistent with a diagnosis of TB infection. Among the spinal TB patients and non-TB disease patients,the overall sensitivity, specificity, positive predictive value, and negative predictive value of the ELISPOT assay in spinal TB diagnosis were 82.7%,87.2%,89.6%, and 79.1%,respectively; the 4 indexes of the PPD skin test were 61.5%, 46.2%, 60.4%, and 47.4%, respectively;those of the antibody detection were 55.8%, 61.5%, 65.9%, and 51.1%. The positive rate of ELISPOT was significantly higher than those of PPD skin test and antibody detection test (82.7% vs. 61.5%, Χ² =5.786, P=0.016; 82.7% vs. 55.8%, Χ² =8.847, P=0.003), but not significantly different from the positive rate of pathological examination (82.7% vs. 87.2%, Χ² =0.396, P=0.529). Moderate agreement was found between pathological examination and the ELISPOT assay (87.2%, Κ=0.498, P=0.001).

Conclusion: With high sensitivity and specificity, the ELISPOT assay using CFP10/ESAT6 fusion protein as antigen is an effective technique for auxiliary diagnosis of spinal TB.

Download full-text PDF

Source
http://dx.doi.org/10.3881/j.issn.1000-503X.2015.01.008DOI Listing

Publication Analysis

Top Keywords

cfp10/esat6 fusion
12
fusion protein
12
elispot assay
12
spinal
9
enzyme-linked immunospot
8
assay cfp10/esat6
8
protein antigen
8
spinal tuberculosis
8
diagnosis spinal
8
spinal patients
8

Similar Publications

(1) Background: Tuberculosis (TB) in humans is a serious chronic epidemic disease caused by (). The diagnosis of TB, especially extra-pulmonary TB (EPTB), is difficult. Isolation of from culture has a low sensitivity in patients with TB and an even lower sensitivity in cases of EPTB.

View Article and Find Full Text PDF

Introduction: This phase I clinical trial was conducted to evaluate the safety of RP22 as a skin test reagent for tuberculosis (TB) diagnosis and to explore the appropriate dosage.

Methods: We used a randomized, double-blind, placebo-controlled identification allergen (IA) skin test. A total of 72 healthy adult volunteers with negative chest X-ray results were randomized into six groups and given a QuantiFERON-TB Gold (QFT) test.

View Article and Find Full Text PDF

An early detection of Mycobacterium tuberculosis is very important to reduce the number of fatal cases and allow for fast recovery. However, the interpretation of the result from smear microscopy requires skilled personnel due to the propensity of the method to produce false-negative results. In this work, a portable, rapid, and simple sandwich-type immunosensor reader has been developed that is able to detect the presence of M.

View Article and Find Full Text PDF

Strong antibody responses to Mycobacterium bovis infection in domestic pigs and potential for reliable serodiagnostics.

Vet Immunol Immunopathol

January 2021

Department of Science and Innovation-National Research Foundation Centre of Excellence for Biomedical TB Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa. Electronic address:

Mycobacterium bovis (M. bovis), the main cause of animal tuberculosis (TB), can infect a wide variety of domestic and wild animal species, including suids. Suids may serve as reservoir hosts or disease sentinels in different scenarios.

View Article and Find Full Text PDF

Development of effective vaccine candidates against tuberculosis is currently the most important challenge in the prevention of this disease since the BCG vaccine fails to guarantee a lifelong protection, while any other approved vaccine with better efficiency is still absent. The protective effect of the recombinant fusion protein ESAT6-CFP10-dIFN produced in a prokaryotic expression system (Escherichia coli) has been assessed in a guinea pig model of acute tuberculosis. The tested antigen comprises the Mycobacterium tuberculosis (Mtb) proteins ESAT6 and CFP10 as well as modified human γ-interferon (dIFN) for boosting the immune response.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!